As per the attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At the 27th AGM held on September 30, 2025, shareholders of Tyche Industries approved a major board restructuring. Mr. Sandeep Gokaraju was appointed as the new Managing Director for a 5-year term effective September 5, 2025, replacing his brother Mr. G. Ganesh Kumar, who was re-designated from Chairman and Managing Director to Executive Director. Mr. Satya Srinivas Uppalapati was appointed as a new Executive Director with over 30 years of pharmaceutical industry experience. Additionally, Mr. Srinivas Gelli was re-designated as a Non-Executive Independent Director, and Mrs. Penumatsa Vijaya Lakshmi was re-appointed as an Independent Director for a second 5-year term.
The change marks a family-led succession at the top, with the Gokaraju brothers now sharing executive responsibilities, which may provide continuity but concentrates decision-making within the promoter family. The addition of an experienced Executive Director and continued independent oversight should support governance stability.